Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Teaching A to Z for a new generation of pharmacy learners.
Medina MS, Pettinger TK, Niemczyk M, Burnworth M. Medina MS, et al. Among authors: pettinger tk. Am J Health Syst Pharm. 2021 Jul 9;78(14):1273-1276. doi: 10.1093/ajhp/zxab174. Am J Health Syst Pharm. 2021. PMID: 33895791 No abstract available.
Practice Transformation Driven through Academic Partnerships.
Robinson R, Liday C, Burde A, Pettinger T, Paul A, Nguyen E, Holmes J, Penner M, Jaglowicz A, Spann N, Boyle J, Biddle M, Buffat B, Cleveland K, Powell B, Owens C. Robinson R, et al. Pharmacy (Basel). 2020 Jul 14;8(3):120. doi: 10.3390/pharmacy8030120. Pharmacy (Basel). 2020. PMID: 32674322 Free PMC article.
Nanopharmaceuticals (part 1): products on the market.
Weissig V, Pettinger TK, Murdock N. Weissig V, et al. Among authors: pettinger tk. Int J Nanomedicine. 2014 Sep 15;9:4357-73. doi: 10.2147/IJN.S46900. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25258527 Free PMC article. Review.
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials.
Mount DL, Feeney P, Fabricatore AN, Coday M, Bahnson J, Byington R, Phelan S, Wilmoth S, Knowler WC, Hramiak I, Osei K, Sweeney ME, Espeland MA; Look AHEAD and ACCORD Research Groups. Mount DL, et al. Clin Trials. 2009 Oct;6(5):416-29. doi: 10.1177/1740774509344440. Epub 2009 Sep 8. Clin Trials. 2009. PMID: 19737845 Free PMC article.
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
ACCORD Study Group; Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT. ACCORD Study Group, et al. N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524. N Engl J Med. 2011. PMID: 21366473 Free PMC article. Clinical Trial.
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group. Ismail-Beigi F, et al. Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Lancet. 2010. PMID: 20594588 Free PMC article. Clinical Trial.
13 results